To determine the molecular mechanism by which ITK inhibitor suppressed cell migration and invasion, we investigated whether ITK inhibitor could modulate motility via C-X-C receptor 4 (CXCR4), focal adhesion kinase (FAK) and RhoA, which is involved in migration and invasion of malignant lymphoma cells [28, 29]. The gene discussed is PTK2; the disease is lymphoma.